Description

Mounjaro is a novel, once-weekly injectable prescription medication for the treatment of type 2 diabetes in adults. It is unique as the first and only dual GIP and GLP-1 receptor agonist. This dual action makes it highly effective at lowering blood sugar and promoting significant weight loss, often outperforming other GLP-1-only medications in clinical trials.